Back to results
US 7,429,673 B2Granted
TRPV1 agonists, formulations containing them and uses thereof
AssigneeIndena S.p.A.
InventorsPaolo Morazzoni, Antonella Riva, Gabriele Fontana, Giovanni Appendino, Vincenzo Di Marzo
Life of this patent
Estimating the term…
Abstract
The compounds of the general formula (I) in which X is represents two hydrogen atoms, a π-bond, oxygen or methylene: R2 is a C6-C12 aryl, or arylalkyl residue: R3 is hydrogen, 2-hydroxyethyl or 2-aminoethyl are useful for the treatment of pathologies mediated by vanilloid receptors type I.
Claims6
A compound of the general formula (I)
- in which
- X represents two hydrogen atoms, a π-bond, oxygen or methylene;
- R2 is a C6-C12 aryl or arylalkyl residue;
- R3 is hydrogen, 2-hydroxyethyl or 2-aminoethyl.
1 more element
Dependencies are inferred from the claim text.